MobiHealth News May 5, 2025
Via Datavant’s data utility and privacy platform, Boehringer Ingelheim can evaluate data and streamline data discovery.
Data sharing technology company Datavant has expanded its collaboration with pharmaceutical company Boehringer Ingelheim to support Boehringer’s real-world evidence initiatives.
The extended collaboration aims to leverage Datavant’s privacy-preserving tokenization and data connectivity technologies to strengthen clinical development and initiate strategies across 75 additional clinical trials and multiple new molecular entities.
Through Datavant Connect, a platform that helps balance data utility with data privacy, Boehringer can adeptly explore and evaluate third-party data sources without moving or sharing underlying data.
By applying Datavant’s technology across a broad portfolio of trials and launches, Boehringer Ingelheim aims to increase the integration of real-world data into drug development.
...Today's Sponsors
Today's Sponsor